{"id":"benzoyl-peroxide-5-gel","safety":{"commonSideEffects":[{"rate":"10-25","effect":"Skin irritation and erythema"},{"rate":"10-20","effect":"Dryness and peeling"},{"rate":"1-5","effect":"Contact dermatitis"},{"rate":null,"effect":"Bleaching of hair or fabrics"}]},"_chembl":null,"_dailymed":{"setId":"a0e4581a-ea6b-4c82-998f-4ea4103c857b","title":"BENZOYL PEROXIDE 5% GEL (BENZOYL PEROXIDE) GEL [AXIA MEDICAL SOLUTIONS, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Benzoyl peroxide is a potent oxidizing agent that penetrates the skin and decomposes to produce oxygen radicals, which are bactericidal against Cutibacterium acnes (formerly Propionibacterium acnes). It also has keratolytic properties that help shed dead skin cells and reduce comedone formation. The 5% concentration provides a balance between efficacy and tolerability for topical acne treatment.","oneSentence":"Benzoyl peroxide kills acne-causing bacteria and promotes skin cell turnover by generating reactive oxygen species.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:22:59.448Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris (mild to moderate)"}]},"trialDetails":[{"nctId":"NCT07473895","phase":"PHASE2","title":"Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT06729450","phase":"NA","title":"Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Kane Biotech Inc","startDate":"2026-01-30","conditions":"Acne Vulgaris on the Face","enrollment":24},{"nctId":"NCT05446402","phase":"PHASE4","title":"Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2022-06-15","conditions":"Acne","enrollment":29},{"nctId":"NCT01044264","phase":"NA","title":"Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":602},{"nctId":"NCT03076320","phase":"PHASE1, PHASE2","title":"Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2017-03-27","conditions":"Acne Vulgaris Superficial Mixed Comedonal and Inflammatory","enrollment":82},{"nctId":"NCT03849885","phase":"PHASE4","title":"Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"Colorado Joint Replacement","startDate":"2019-02-02","conditions":"Degenerative Osteoarthritis","enrollment":496},{"nctId":"NCT04000347","phase":"PHASE4","title":"A Study of Efficacy of Benzoyl Peroxide Regimens in Treatment of Unpleasant Foot Odor","status":"WITHDRAWN","sponsor":"Mahidol University","startDate":"2019-06-26","conditions":"Benzoyl Peroxide, Foot Dermatoses","enrollment":""},{"nctId":"NCT05469880","phase":"NA","title":"Efficacy and Tolerance of Formula 609613 37 in Acneic Patients","status":"COMPLETED","sponsor":"Cosmetique Active International","startDate":"2009-10-21","conditions":"Acne","enrollment":100},{"nctId":"NCT04300010","phase":"PHASE4","title":"Blue Light Therapy of C. Acnes","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-10-05","conditions":"Acne","enrollment":60},{"nctId":"NCT01138514","phase":"PHASE3","title":"Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":1555},{"nctId":"NCT02589405","phase":"PHASE4","title":"Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2015-08","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT00441415","phase":"PHASE3","title":"Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-02","conditions":"Acne Vulgaris","enrollment":272},{"nctId":"NCT02005666","phase":"PHASE3","title":"To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel","status":"COMPLETED","sponsor":"Zydus Lifesciences Limited","startDate":"2013-11","conditions":"Acne Vulgaris","enrollment":850},{"nctId":"NCT03257202","phase":"PHASE2","title":"Topical Treatment and Prevalence of P. Acnes","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2017-09-11","conditions":"Surgical Site Infection","enrollment":12},{"nctId":"NCT00658112","phase":"PHASE4","title":"Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2006-07","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01176955","phase":"NA","title":"A Novel Method to Improve Acne Outcomes","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT00757523","phase":"PHASE4","title":"Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-09-10","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT01428466","phase":"PHASE1","title":"Japanese Phase 1 Study of GSK2585823","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11-18","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT02465632","phase":"PHASE3","title":"To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":1100},{"nctId":"NCT01132443","phase":"PHASE1","title":"W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2010-05-06","conditions":"Acne Vulgaris","enrollment":72},{"nctId":"NCT00964366","phase":"PHASE4","title":"Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":53},{"nctId":"NCT02595034","phase":"PHASE1","title":"A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-01","conditions":"Acne Vulgaris","enrollment":1000},{"nctId":"NCT01015638","phase":"PHASE4","title":"Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT02073461","phase":"PHASE2","title":"Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-03","conditions":"Acne Vulgaris","enrollment":236},{"nctId":"NCT00713609","phase":"PHASE2","title":"Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-06","conditions":"Acne Vulgaris","enrollment":591},{"nctId":"NCT01915732","phase":"PHASE3","title":"A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-04","conditions":"Acne Vulgaris","enrollment":1018},{"nctId":"NCT01016977","phase":"PHASE4","title":"A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT02052752","phase":"PHASE4","title":"A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02","conditions":"Skin Diseases","enrollment":90},{"nctId":"NCT01769664","phase":"PHASE1","title":"A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-09","conditions":"Acne Vulgaris","enrollment":650},{"nctId":"NCT01231334","phase":"PHASE4","title":"A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-08","conditions":"Acne Vulgaris","enrollment":286},{"nctId":"NCT01313728","phase":"PHASE4","title":"A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2010-12","conditions":"Acne Vulgaris","enrollment":26},{"nctId":"NCT00907257","phase":"PHASE4","title":"A Study of Different Use Regimens Using Two Acne Treatments","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":247},{"nctId":"NCT00624676","phase":"NA","title":"Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Cosmetique Active International","startDate":"2006-01","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT00151541","phase":"PHASE3","title":"A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%","status":"COMPLETED","sponsor":"Allergan","startDate":"2005-02","conditions":"Acne Vulgaris","enrollment":301},{"nctId":"NCT01052246","phase":"NA","title":"Pulsed Dye Laser Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Laserklinik Karlsruhe","startDate":"2008-10","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT00377000","phase":"PHASE4","title":"A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2005-11","conditions":"Acne Vulgaris","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Benzoyl peroxide 5% gel","genericName":"Benzoyl peroxide 5% gel","companyName":"University of Southern California","companyId":"university-of-southern-california","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Benzoyl peroxide kills acne-causing bacteria and promotes skin cell turnover by generating reactive oxygen species. Used for Acne vulgaris (mild to moderate).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}